Response: Effects of 6 Months of Dapagliflozin Treatment on Metabolic Profile and Endothelial Cell Dysfunction for Obese Type 2 Diabetes Mellitus Patients without Atherosclerotic Cardiovascular Disease (J Obes Metab Syndr 2020;29:215-21)

J Obes Metab Syndr. 2021 Mar 30;30(1):74-75. doi: 10.7570/jomes21006.

Authors

Ju-Young Hong¹, Keun-Young Park¹, Jong-Dai Kim¹, Won-Min Hwang², Dong-Mee Lim^{1

3}

Affiliations

¹ Division of Endocrinology, Department of Internal Medicine, Konyang University College of Medicine, Daejeon, Korea.
² Division of Nephrology, Department of Internal Medicine, Konyang University College of Medicine, Daejeon, Korea.
³ Konyang University Myunggok Medical Research Institute, Daejeon, Korea.

No abstract available